Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

Investigator: Bincy Abraham, MD

Study Coordinator:

Status: Enrolling Number: NCT03440372


Protocol Number: Pro00019985


This is a study to explore the effect of oral ozanimod as an induction treatment for participants with moderately to severely active Crohn's Disease.
More to Explore